These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36459969)

  • 1. A reference human induced pluripotent stem cell line for large-scale collaborative studies.
    Pantazis CB; Yang A; Lara E; McDonough JA; Blauwendraat C; Peng L; Oguro H; Kanaujiya J; Zou J; Sebesta D; Pratt G; Cross E; Blockwick J; Buxton P; Kinner-Bibeau L; Medura C; Tompkins C; Hughes S; Santiana M; Faghri F; Nalls MA; Vitale D; Ballard S; Qi YA; Ramos DM; Anderson KM; Stadler J; Narayan P; Papademetriou J; Reilly L; Nelson MP; Aggarwal S; Rosen LU; Kirwan P; Pisupati V; Coon SL; Scholz SW; Priebe T; Öttl M; Dong J; Meijer M; Janssen LJM; Lourenco VS; van der Kant R; Crusius D; Paquet D; Raulin AC; Bu G; Held A; Wainger BJ; Gabriele RMC; Casey JM; Wray S; Abu-Bonsrah D; Parish CL; Beccari MS; Cleveland DW; Li E; Rose IVL; Kampmann M; Calatayud Aristoy C; Verstreken P; Heinrich L; Chen MY; Schüle B; Dou D; Holzbaur ELF; Zanellati MC; Basundra R; Deshmukh M; Cohen S; Khanna R; Raman M; Nevin ZS; Matia M; Van Lent J; Timmerman V; Conklin BR; Johnson Chase K; Zhang K; Funes S; Bosco DA; Erlebach L; Welzer M; Kronenberg-Versteeg D; Lyu G; Arenas E; Coccia E; Sarrafha L; Ahfeldt T; Marioni JC; Skarnes WC; Cookson MR; Ward ME; Merkle FT
    Cell Stem Cell; 2022 Dec; 29(12):1685-1702.e22. PubMed ID: 36459969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteome remodeling characterization of two human reference pluripotent stem cell lines during neurogenesis and cardiomyogenesis.
    Nam KH; Ordureau A
    Proteomics; 2022 Oct; 22(19-20):e2100246. PubMed ID: 35871287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High density SNP array and reanalysis of genome sequencing uncovers CNVs associated with neurodevelopmental disorders in KOLF2.1J iPSCs.
    Gracia-Diaz C; Perdomo JE; Khan ME; Disanza B; Cajka GG; Lei S; Gagne A; Maguire JA; Roule T; Shalem O; Bhoj EJ; Ahrens-Nicklas RC; French D; Goldberg EM; Wang K; Glessner J; Akizu N
    bioRxiv; 2023 Jun; ():. PubMed ID: 37425875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA integrity and metabolome profile are preserved in the human induced pluripotent stem cell reference line KOLF2.1J.
    Dobner J; Nguyen T; Dunkel A; Prigione A; Krutmann J; Rossi A
    Stem Cell Reports; 2024 Mar; 19(3):343-350. PubMed ID: 38402620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
    Getachew H; Chinchilla B; Fernandez-Godino R
    Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Monoclonal iPSC Lines with Stable Cas9 Expression and High Cas9 Activity.
    Liao JQ; Zhou G; Zhou Y
    Methods Mol Biol; 2022; 2454():575-588. PubMed ID: 32567018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
    Ben Jehuda R; Shemer Y; Binah O
    Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
    Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
    Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages.
    Navarro-Guerrero E; Tay C; Whalley JP; Cowley SA; Davies B; Knight JC; Ebner D
    Sci Rep; 2021 Feb; 11(1):4245. PubMed ID: 33608581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy.
    Kehler J; Greco M; Martino V; Pachiappan M; Yokoe H; Chen A; Yang M; Auerbach J; Jessee J; Gotte M; Milanesi L; Albertini A; Bellipanni G; Zucchi I; Reinbold RA; Giordano A
    J Cell Physiol; 2017 Jun; 232(6):1262-1269. PubMed ID: 27631155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
    Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
    Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
    Li M; Hunt JFVS; Bhattacharyya A; Zhao X
    Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
    Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing.
    Gulimiheranmu M; Li S; Zhou J
    Stem Cell Res; 2022 Jul; 62():102805. PubMed ID: 35576811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.